Publication | Closed Access
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors
44
Citations
13
References
2014
Year
OncologyLiposomal Docetaxel FormulationMedicineAdvanced Solid TumorsPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1